An Immunohistochemical Study of ErbB4 Receptor in Alzheimer’s Disease Hippocampus

다국어 초록 (Multilingual Abstract)

Neuregulin-1 (NRG1) signaling participates in numerous neurodevelopmental processes. Although ErbB4, a key NRG1 receptor, is expressed in multiple regions in the adult animal brain, little is known about its expression in aged human brain. We show that ErbB4 immunoreactivity was shown regional difference in the hippocampus of age-matched control and that the distribution of these molecules was altered in Alzheimer’s disease (AD) brains.
Immunohistochemical characterization of the distribution of ErbB4 receptor in the hippocampus relative to pathology staging were performed in age-matched control (Braak stage Ⅰ/Ⅱ, n=5), early AD (Braak stage Ⅲ/Ⅳ, n=5) and advanced AD(Braak stage Ⅴ/Ⅵ, n=10). The intensity of ErbB4 immunoreactivity was higher in neurons of the CA2 than that in CA1 or CA3 in the age-matched control. Particularly, in the early AD, ErbB4 immunoreactivity was significantly increased in the apoptotic cells of the CA2 field. In the advanced AD, ErbB4 immunostaining was more intense in the apoptotic cell of the CA2 field. In the dentate gyrus (DG), ErbB4-positive granular cell density was gradually increased in proportion to the progression of pathology of AD brains. We have also found that ErbB4 immunostaining was increased in the nucleus, suggesting that the presenilin-dependent cleavage of ErbB4 generates the soluble ErbB4 ICD (intracellular domain) that translocalized to the nucleus. Together, these results provide the immunohistochemical analysis of ErbB4 receptor in the human hippocampus staged by the progression of pathology of AD.

참고문헌 (Reference)

1 Li Y, "neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia" 1184 : 277-283, 2007

2 Li B, "The neuregulin-1 receptor ErbB4 controls glutamatergic synapse maturation and plasticity" 54 : 583-597, 2007

3 Garcia RA, "The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses" 97 : 3596-3601, 2000

4 Harrison PJ, "The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications" 174 : 151-162, 2004

5 Bublil EM, "The EGF receptor family: spearheading a merger of signaling and therapeutics" 19 : 124-134, 2007

6 Lopez-Bendito G, "Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation" 125 : 127-142, 2006

7 Anton ES, "Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex" 124 : 3501-3510, 1997

8 Huang YZ, "Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses" 26 : 443-455, 2000

9 Wang YT, "Regulation of NMDA receptors by tyrosine kinases and phosphatases" 369 : 233-235, 1994

10 Croslan DR, "Neuroprotective effects of neuregulin- 1 on B35 neuronal cells following ischemia" 1210 : 39-47, 2008

11 Braak H, "Neuropathological stageing of Alzheimer-related changes" 82 : 239-259, 1991

12 Gerecke KM, "Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons" 27 : 379-393, 2004

13 Woo RS, "Neuregulin-1 enhances depolarization-induced GABA release" 54 : 599-610, 2007

14 Chaudhury AR, "Neuregulin-1 and ErbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease" 62 : 42-54, 2003

15 Shyu WC, "Neuregulin- 1 reduces ischemia-induced brain damage in rats" 25 : 935-944, 2004

16 Calaora V, "Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro" 21 : 4740-4751, 2001

17 Goldshmit Y, "Neuregulin rescues PC12-ErbB4 cells from cell death induced by H(2)O(2). Regulation of reactive oxygen species levels by phosphatidylinositol 3-kinase" 276 : 46379-46385, 2001

18 Rio C, "Neuregulin and ErbB receptors play a critical role in neuronal migration" 19 : 39-50, 1997

19 Buonanno A, "Neuregulin and ErbB receptor signaling pathways in the nervous system" 11 : 287-296, 2001

20 Corfas G, "Neuregulin 1-ErbB signaling and the molecular/cellular basis of schizophrenia" 7 : 575-580, 2004

21 Yau HJ, "Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences" 13 : 252-264, 2003

22 Tilley L, "Genetic risk factors in Alzheimer’s disease" 51 : 293-304, 1998

23 Fernandez PA, "Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve" 28 : 81-90, 2000

24 Pitcher GM, "ErbB4 is a suppressor of long-term potentiation in the adult hippocampus" 19 : 139-143, 2008

25 Bermingham-McDonogh O, "Effects of GGF/ neuregulins on neuronal survival and neurite outgrowth correlate with ErbB2/neu expression in developing rat retina" 122 : 1427-1438, 1996

26 Li BS, "Cyclin-dependent kinase-5 is involved in neuregulin- dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival" 278 : 35702-35709, 2003

27 Lewis DA, "Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations" 63 : 1372-1376, 2006

28 Campbell SK, "Alzheimers Plaques and Tangles: A controled and enhanced silver staining method" 678-, 1987